What to consider before conducting a decentralized clinical trial [checklist]

During the COVID-19 pandemic, many clinical trials adapted by adding virtual elements to their traditional trial approaches. While many could not go fully virtual due to the need to collect samples at specific milestones and check on patients in person, folding in technology kept patients safer and reduced the burden to participation. In many cases, it allowed research to stay on track while the world shut down.

When a trial is flexible in this way, including both elements of virtual trials and traditional trials and keeping patient burden low, it is referred to as a “decentralized trial.” For sponsors considering decentralizing their clinical trials, it’s important to be fully prepared for this new approach.

Are you ready to conduct a decentralized clinical trial? In our checklist, we share a blueprint of considerations before running a decentralized clinical trial.